Table 3.
Onset, LOS, and Discharge Status, by Carbapenem-Resistant Pathogen
| Carbapenem-Resistant Pathogensa | |||||
|---|---|---|---|---|---|
| Stenotrophomonas maltophilia | Acinetobacter baumannii | Pseudomonas aeruginosa | Klebsiella pneumoniae | Proteus mirabilis | |
| Classification of infection, % | |||||
| Community-onset infection | 44.6 | 0 | 0.5 | 0.4 | 0 |
| Health care–associated infection | 6.6 | 40.4 | 42.5 | 44.3 | 73.9 |
| Hospital-acquired infection | 48.8 | 59.6 | 57.0 | 55.3 | 26.1 |
| Infection-associated length of stay, d | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Mean (SD) | 13.2 (19.8) | 12.9 (16.3) | 16.3 (22.6) | 15.0 (20.7) | 9.9 (8.9) |
| Median (min–max) | 9 (0–353) | 9 (1–143) | 10 (1–197) | 10 (1–187) | 7 (2–50) |
| Discharge status, % | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Discharge to home | 60.9 | 7.7 | 23.2 | 15.8 | 26.1 |
| Discharge to hospice | 2.3 | 2.1 | 6.3 | 10.7 | 6.1 |
| Discharge to other facilities (eg, skilled nursing facility) | 24.1 | 47.7 | 46.2 | 53.0 | 60.9 |
| In-hospital mortality | 12.8 | 47.7 | 24.3 | 20.6 | 7.0 |
Abbreviation: LOS, length of stay.
aPathogens were considered carbapenem-resistant if the interpretation for any carbapenem was listed as resistant or intermediate, excluding ertapenem for A. baumannii and P. aeruginosa.